Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Marty Duvall
|
| gptkbp:focusesOn |
oncology
gene therapy |
| gptkbp:foundedIn |
2007
|
| gptkbp:founder |
Harry Gruber
Stephen B. Hurst |
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tocagen
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mergedInto |
2020
Forte Biosciences |
| gptkbp:notableProduct |
Toca 511
Toca FC |
| gptkbp:publiclyTraded |
NASDAQ:TOCA
|
| gptkbp:status |
defunct
|
| gptkbp:website |
https://www.tocagen.com/
|
| gptkbp:bfsParent |
gptkb:Sorrento_Mesa
|
| gptkbp:bfsLayer |
8
|